{'byline': '', 'hosts': '', 'byline_sources': '', 'hide_author': True, 'audience_id': '', 'original_station': [{'station': 'wearechannelq', 'path': 'wearechannelq/latest/cvs-denies-coverage-for-breakthrough-hiv-prevention-drug'}], 'syndicated_items': '', 'original_item': {'_index': 'published-content_v44', '_type': '_doc', '_score': None, '_source': {'date': '2025-08-26T17:09:19.190Z', 'lead': [{'data': {'alt': 'Getty', 'url': 'https://radioimg.audacy.com/aiu-media/lgbtq-cvs-logo-a6c0dafb-37f6-48ce-abe5-5536ba3d271f.jpg', 'width': 594, 'credit': 'Getty Images', 'height': 395, 'caption': None, '_version': 1, 'imageLink': None, 'rendition': None, 'sizeInBytes': '53964', 'borderToggle': None, 'componentVariation': 'image'}, 'original_ref': 'www.audacy.com/_components/image/instances/cmesst2l40015357t2xf16l13@published'}], 'slug': 'cvs-denies-coverage-for-breakthrough-hiv-prevention-drug', 'tags': [], 'feeds': {'msn': True, 'rss': True, 'postup': True, 'facebook': True, 'newsfeed': True, 'sitemaps': True, 'frequency': True, 'smartNews': True, 'apple-news': False, 'smart-news': True, 'most-popular': True, 'reversechron': True, 'google-news-feed': True}, 'hosts': [], 'adTags': {'original_ref': 'www.audacy.com/_components/ad-tags/instances/cmessr1pe000a01ui9qttbqku@published'}, 'byline': [{'names': [], 'sources': [], 'hosts': [], 'prefix': 'by'}], 'teaser': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'authors': [], 'content': [{'data': {'text': 'In a move sparking outrage across the LGBTQ+ community, CVS Health is refusing to cover <em>Yeztugo</em> — a groundbreaking HIV prevention injection — despite its near-total effectiveness.', '_version': 2, 'componentVariation': 'paragraph'}, 'original_ref': 'www.audacy.com/_components/paragraph/instances/cmessr1pe000e01ui36jqfli9@published'}, {'data': {'text': 'The drug, given just twice a year, was FDA-approved in June and reduces HIV risk by 96%, especially among trans, nonbinary, and queer men who have sex with men.', '_version': 2, 'componentVariation': 'paragraph'}, 'original_ref': 'www.audacy.com/_components/paragraph/instances/cmessr6o0000h357tj89oboaf@published'}, {'data': {'text': 'But CVS says the $28,000-a-year cost is too high, and won’t cover it under private or ACA plans.', '_version': 2, 'componentVariation': 'paragraph'}, 'original_ref': 'www.audacy.com/_components/paragraph/instances/cmessr6r4000i357tkqecyydi@published'}, {'data': {'text': 'HIV advocates call the move dangerous and discriminatory, accusing CVS of blocking access to life-saving care.', '_version': 2, 'componentVariation': 'paragraph'}, 'original_ref': 'www.audacy.com/_components/paragraph/instances/cmessr6u6000j357tgykpkshq@published'}, {'data': {'text': 'Gilead, the drug’s maker, says most insurers <em>are</em> covering it — and expects near-universal coverage by next year. Story first appeared at <a href="https://www.advocate.com/health/cvs-health-denies-yeztugo-coverage">advocate.com</a>', '_version': 2, 'componentVariation': 'paragraph'}, 'original_ref': 'www.audacy.com/_components/paragraph/instances/cmessr6xj000k357taft49gwx@published'}], 'feedImg': {'data': {'alt': 'Getty', 'url': 'https://radioimg.audacy.com/aiu-media/lgbtq-cvs-logo-a6c0dafb-37f6-48ce-abe5-5536ba3d271f.jpg', 'width': 594, 'credit': 'Getty Images', 'height': 395, 'caption': None, '_version': 1, 'mimeType': 'image/jpeg', 'imageLink': None, 'rendition': None, 'sizeInBytes': '53964', 'borderToggle': None, 'componentVariation': 'image'}, 'original_ref': 'www.audacy.com/_components/feed-image/instances/cmessr1pe000b01uiay6vrjv8@published'}, 'sources': [], '_version': 24, 'featured': False, 'headline': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'msnTitle': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'textTags': [], '_msnTitle': {'shouldOverride': False}, 'apContent': None, 'isOpinion': False, 'pageTitle': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'sideShare': {'original_ref': 'www.audacy.com/_components/share/instances/cmessr1pe000c01ui16zrt3nv@published'}, 'feedImgUrl': 'https://radioimg.audacy.com/aiu-media/lgbtq-cvs-logo-a6c0dafb-37f6-48ce-abe5-5536ba3d271f.jpg', 'feedLayout': 'small', 'showSocial': True, 'stationURL': 'https://www.audacy.com/wearechannelq', 'breadcrumbs': [{'hidden': False, 'text': 'CHANNEL Q', 'url': '//www.audacy.com/wearechannelq'}, {'hidden': False, 'text': 'LATEST', 'url': '//www.audacy.com/wearechannelq/latest'}], 'contentType': 'article', 'seoHeadline': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'stationName': 'CHANNEL Q', 'stationSlug': 'wearechannelq', 'dateModified': '2025-08-26T17:09:22.816Z', 'featuredNews': True, 'sectionFront': 'latest', 'fullWidthLead': False, 'shortHeadline': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'syndicatedUrl': None, 'unityPageType': 'article', 'featuredSports': False, 'msnTitleLength': 56, 'seoDescription': 'n a move sparking outrage across the LGBTQ+ community, CVS Health is refusing to cover Yeztugo — a groundbreaking HIV prevention injection — despite its near-total effectiveness.', 'stationLogoUrl': 'https://radioimg.audacy.com/aud-opsconsole-media-images-prod-prod/logos/KNXHD2.jpg', 'isContentFromAP': False, 'noIndexNoFollow': False, 'pageDescription': 'n a move sparking outrage across the LGBTQ+ community, CVS Health is refusing to cover Yeztugo — a groundbreaking HIV prevention injection — despite its near-total effectiveness.', 'primaryHeadline': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'stationCallsign': 'KNXHD2', 'stationTimezone': 'US/Pacific', 'socialDescription': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'syndicationStatus': 'original', 'componentVariation': 'article', 'stationSyndication': [], 'hasSecondaryBylines': False, 'rollingStandoutCount': 0, 'secondarySectionFront': None, 'contentPageSponsorLogo': {'original_ref': 'www.audacy.com/_components/google-ad-manager/instances/cmessr1pe000d01uij9n7yjj9@published'}, 'displayLogoSponsorship': False, 'plaintextShortHeadline': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', '_opinionHeadlineOverride': {'shouldOverride': False}, 'plaintextPrimaryHeadline': 'CVS Denies Coverage for Breakthrough HIV Prevention Drug', 'canBeMarkedGoogleStandout': True, 'isContentFromNoIndexByline': False, 'availableStandoutArticleInventory': True, 'articleWithinGoogleStandoutPublishDateLimit': True, 'canonicalUrl': 'http://www.audacy.com/wearechannelq/latest/cvs-denies-coverage-for-breakthrough-hiv-prevention-drug', 'site': 'demo', 'slugLock': True}, 'sort': [1865818], 'stationSlug': 'wearechannelq', 'original_id': 'www.audacy.com/_components/article/instances/cmessr1pe000f01ui6d6mif0k@published'}}